Ad
related to: gene therapy for inherited diseases and disorders journal articles- Publish Open Access
Every article is freely available.
Achieve maximum readership.
- Join A Research Topic
Highly cited & widely read research
Achieve more views & downloads
- Submit Your Research
Journals led by external experts
Community-run publishing
- Become An Editor
Where scientists empower society
3rd most-cited publisher
- Publish Open Access
Search results
Results from the WOW.Com Content Network
Gene therapy approaches to replace a faulty gene with a healthy gene have been proposed and are being studied for treating some genetic diseases. As of 2017, 11.1% of gene therapy clinical trials targeted monogenic diseases. [74]: 9
The journal publishes articles concerning basic research and clinical applications of gene and cell therapy of diseases including new scientific methods, gene delivery systems, gene therapy treatments, as well as approaches to genetic modification with the aim of treating disease. A more recent focus of the journal includes Cell Therapy, with ...
Beta thalassemia is a heritable disorder, characterized by the inability to make beta globin protein, and in turn reduced functioning of hemoglobin (which beta globin is a part of). [8] In December 2023, the European Medicines Agency recommended approval for a cell based gene therapy that works through the CRISPR/Cas9 system.
The approval is expected to raise new questions about how the United States pays for major medical breakthroughs.
The gene therapy will compete with Australia-based CSL Behring’s Hemgenix, a similar treatment that won FDA approval for hemophilia B in 2022. That drug has a similar list price of $3.5 million ...
Exagamglogene autotemcel (Casgevy): treatment for sickle cell disease. [11] Gendicine: treatment for head and neck squamous cell carcinoma; Idecabtagene vicleucel (Abecma): treatment for multiple myeloma [12] Lovotibeglogene autotemcel (Lyfgenia): treatment for sickle cell disease. [11] Nadofaragene firadenovec (Adstiladrin): treatment for ...
Gene therapy has allowed several children born with inherited deafness to hear. On Tuesday, the Children's Hospital of Philadelphia announced similar improvements in an 11-year-old boy treated there.
Retinal gene therapy holds a promise in treating different forms of non-inherited and inherited blindness. In 2008, three independent research groups reported that patients with the rare genetic retinal disease Leber's congenital amaurosis had been successfully treated using gene therapy with adeno-associated virus (AAV).
Ad
related to: gene therapy for inherited diseases and disorders journal articles